Stockscreener 앱 받기
1.68
0.00%
0.00
시간 외 거래:
1.68
전일 마감가:
$1.68
열려 있는:
$1.68
하루 거래량:
2,197
Relative Volume:
34.41
시가총액:
$N/A
수익:
$3.13M
순이익/손실:
$-40.29M
주가수익비율:
-0.375
EPS:
-4.48
순현금흐름:
$-33.08M
1주 성능:
+7.81%
1개월 성능:
-60.53%
6개월 성능:
+427.32%
1년 성능:
+221.67%
1일 변동 폭
$1.61
$1.74
1주일 범위
$1.61
$1.74
52주 변동 폭
$1.61
$1.74
Trevena Inc Stock (TRVN) Company Profile
TRVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| TRVN | 1.68 | 0 | 3.13M | -40.29M | -33.08M | -4.48 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Trevena Inc Stock (TRVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-15 | 개시 | Oppenheimer | Perform |
| 2020-09-14 | 개시 | Guggenheim | Buy |
| 2020-08-28 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-05-31 | 재개 | H.C. Wainwright | Buy |
| 2018-11-05 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2018-10-12 | 다운그레이드 | Needham | Buy → Hold |
| 2018-10-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2017-11-08 | 재확인 | Needham | Buy |
| 2017-10-16 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2017-10-12 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-08 | 재확인 | Needham | Buy |
| 2017-02-23 | 재확인 | H.C. Wainwright | Buy |
| 2017-02-22 | 재확인 | FBR & Co. | Outperform |
| 2017-02-02 | 개시 | Ladenburg Thalmann | Buy |
| 2017-01-09 | 개시 | H.C. Wainwright | Buy |
| 2017-01-05 | 개시 | Oppenheimer | Outperform |
| 2016-05-17 | 재확인 | FBR Capital | Outperform |
| 2016-05-17 | 재확인 | Needham | Buy |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2015-09-01 | 재확인 | Wedbush | Outperform |
| 2015-08-03 | 개시 | Brean Capital | Buy |
모두보기
Trevena Inc 주식(TRVN)의 최신 뉴스
Post-operative Pain Therapeutics Market Future Prospects, - openPR
ARMISTICE CAPITAL, LLC Acquires New Stake in Trevena Inc - GuruFocus.com
Trevena downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
Trevena Inc. Reports Q3 2024 Financial Results - TipRanks
Ultragenyx Q3 Loss Narrower Than Expected, Revenues Beat Estimates - MSN
Trevena, Inc. Navigates Financial Challenges and Strategic Changes - MyChesCo
Postoperative Pain Therapeutics Market Trends, Business Overview, Industry Growth and Forecast to 2031 - openPR
Trevena Inc. (TRVN) Quarterly 10-Q Report - Quartz
Chester County biopharm firm's latest layoffs impact its C-suite - The Business Journals
Trevena: Q3 Earnings Snapshot - San Francisco Chronicle
Trevena Faces Leadership Changes Amidst Financial Challenges - TipRanks
Trevena, Inc. Announces Board Changes - Marketscreener.com
Trevena Reports Third Quarter 2024 Results and Provides Business Update - StockTitan
CVS Health books $1.2 bn in restructuring charges with new CEO comments in focus - MSN
Why Viking Therapeutics Stock Plummeted After Soaring Today - MSN
23andMe appoints new board members as it works to stem the company's slide - MSN
Sequoia buys South Carolina RIA Family Asset Management - MSN
Opioids Market Size to be worth $15.03 Billion By 2031: The Insight Partners - finanznachrichten.de
Trevena Announces Reverse Stock Split to Regain Nasdaq Compliance - MSN
Post Operative Pain Therapeutics Market to Witness Huge Growth - openPR
Opioid treatment market set to grow despite expected slump in US sale value - Pharmaceutical Technology
Savara Inc. Rewards New Employees with Inducement Awards - MyChesCo
Wendel Buys Majority Stake in US Private Credit Manager Monroe - MSN
Opioid addiction market to reach $2.4 billion across 8MM by 2033 - Pharmaceutical Technology
Why Trevena (TRVN) Stock Is Down 43% Today - MSN
TREVENA announces executive terminations and consulting agreements - Investing.com India
TREVENA announces executive terminations and consulting agreements By Investing.com - Investing.com South Africa
United States shares lower at close of trade; Dow Jones Industrial Average down 0.94% - MSN
Trevena Executives Terminated but Remain as Advisors - TipRanks
Cantaloupe, Inc. Executives Boost Confidence with Significant Stock Purchases - MyChesCo
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.94% - Investing.com
Dow Tumbles Over 400 Points; Duckhorn Portfolio Shares Surge - Benzinga
Crude Oil Gains Over 3%; Scholar Rock Shares Spike Higher - Benzinga
Trevena stock hits 52-week low at $2.5 amid market challenges - Investing.com India
Why Arcadium Lithium Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket - Benzinga
StockNews.com Initiates Coverage on Trevena (NASDAQ:TRVN) - MarketBeat
Trevena, Inc. Faces Delisting from Nasdaq - MSN
Downtown Fremont to host Sauerkraut Social Event - MSN
Trevena to be delisted from Nasdaq over equity shortfall - Investing.com India
Trevena to be delisted from Nasdaq over equity shortfall By Investing.com - Investing.com South Africa
Trevena Gets Nasdaq Delisting Notice; Trading to Be Suspended Tuesday - Marketscreener.com
Trevena Announces Receipt of Nasdaq Delisting Notification - ForexTV.com
Trevena Faces Nasdaq Delisting and Uncertain OTC Future - TipRanks
Sheetz introduces its customizable chicken nuggets - MSN
Postoperative Pain Therapeutics Service Market Size, Market Evolution in the Digital Age (2024-2034) - உங்கள் குரல்
Trevena's SWOT analysis: stock outlook amid pipeline progress, strategic shifts By Investing.com - Investing.com South Africa
Trevena's SWOT analysis: stock outlook amid pipeline progress, strategic shifts - Investing.com
Opioid Market Size Anticipated to Climb to USD 26.41 Billion with - openPR
Pisces Horoscope for September 28, 2024 - MSN
Trevena Inc (TRVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):